Literature DB >> 10695581

Dietary therapy for children with hypercholesterolemia.

R Shamir1, E A Fisher.   

Abstract

Accumulating evidence clearly shows that atherosclerosis begins in youth. The National Cholesterol Education Program (NCEP) has recommended that children at high risk of developing coronary artery disease as adults be screened so that those with elevated low-density lipoprotein (LDL) cholesterol levels can be treated, primarily by modification of diet. The initial approach to these youthful patients is to use the NCEP step I diet. This diet provides calories and nutrients that support normal growth and development, but limits saturated fat and total fat intake to no more than 10 and 30 percent of total calories, respectively, and cholesterol intake to no more than 100 mg per 1,000 kcal per day, to a maximum of 300 mg. If the goal of reducing the LDL cholesterol level to below 130 mg per dL (3.35 mmol per L) is not achieved, the more restrictive step II diet should be initiated. However, the step II diet may not provide sufficient calories and nutrients to support normal growth and development; therefore, trained nutritionists may be required to effectively manage a child on this diet.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695581

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

Review 1.  Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.

Authors:  L Iughetti; B Predieri; F Balli; S Calandra
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 2.  Herbs with anti-lipid effects and their interactions with statins as a chemical anti- hyperlipidemia group drugs: A systematic review.

Authors:  Hojjat Rouhi-Boroujeni; Hamid Rouhi-Boroujeni; Esfandiar Heidarian; Fereshteh Mohammadizadeh; Mahmoud Rafieian-Kopaei
Journal:  ARYA Atheroscler       Date:  2015-07

3.  Effects of Ferulago angulata Extract on Serum Lipids and Lipid Peroxidation.

Authors:  Mahmoud Rafieian-Kopaei; Najmeh Shahinfard; Hojjat Rouhi-Boroujeni; Mojgan Gharipour; Pariya Darvishzadeh-Boroujeni
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-24       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.